BioSpecifics Technologies Corporation Reports Fourth Quarter and Full Year 2012 Financial Results

Published: Mar 13, 2013

LYNBROOK, N.Y., March 12, 2013 -- /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S., today announced its financial results for the fourth quarter and full year ended December 31, 2012 and provided a corporate update.

Back to news